Provided by Tiger Fintech (Singapore) Pte. Ltd.

Actinium Pharmaceuticals

1.52
+0.09006.29%
Pre-market: 1.51-0.0100-0.66%06:18 EDT
Volume:529.02K
Turnover:760.22K
Market Cap:47.42M
PE:-1.20
High:1.52
Open:1.43
Low:1.35
Close:1.43
Loading ...

Actinium Pharmaceuticals Continues R&D Focus Amid Financial Progress

TIPRANKS
·
19 Nov 2024

Actinium highlights development updates for Iomab-B, Actimab-A, Iomab-ACT

TIPRANKS
·
18 Nov 2024

Actinium Pharmaceuticals Q3 EPS $(0.37) Misses $(0.30) Estimate

Benzinga
·
18 Nov 2024

Actinium Pharmaceuticals Highlights Antibody Radiation Conjugate Program Developments and Reports Financial Results for the Third Quarter 2024

THOMSON REUTERS
·
18 Nov 2024

Actinium Pharmaceuticals Highlights Antibody Radiation Conjugate Program Developments and Reports Financial Results for the Third Quarter 2024

PR Newswire
·
18 Nov 2024

Actinium Pharmaceuticals Price Target Maintained With a $4.00/Share by HC Wainwright & Co.

Dow Jones
·
16 Nov 2024

Optimistic Buy Rating for Actinium Pharmaceuticals Driven by Strategic Progress and Promising Pipeline

TIPRANKS
·
15 Nov 2024

Actinium: Q3 Earnings Snapshot

Associated Press Finance
·
15 Nov 2024

Actinium Pharmaceuticals Strengthens Board with New Appointment

TIPRANKS
·
06 Nov 2024

BRIEF-Actinium Pharmaceuticals Appoints Accomplished Biopharma Industry Executive June Almenoff To Its Board Of Directors

Reuters
·
04 Nov 2024

Actinium Pharmaceuticals Appoints Accomplished Biopharma Industry Executive June Almenoff, M.d., Ph.d. to Its Board of Directors

THOMSON REUTERS
·
04 Nov 2024

Press Release: Actinium Pharmaceuticals Appoints Accomplished Biopharma Industry Executive June Almenoff, M.D., Ph.D. to its Board of Directors

Dow Jones
·
04 Nov 2024

North American Morning Briefing: Traders Level Out Positions Ahead of Election

Dow Jones
·
04 Nov 2024